Literature DB >> 16055108

Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.

Gulden Baskol1, Huseyin Demir, Mevlut Baskol, Eser Kilic, Filiz Ates, Derya Kocer, Sabahattin Muhtaroglu.   

Abstract

OBJECTIVES: We aimed to evaluate antioxidant paraoxonase 1 activity together with malondialdehyde (MDA) (an oxidative stress parameter) levels in patients with rheumatoid arthritis. DESIGN AND METHODS: Fifty-seven rheumatoid arthritis patients were included in the study and subgrouped according to disease activity (active, n = 31; inactive, n = 26) and compared with healthy controls (n = 25). Serum paraoxonase 1 activity and MDA levels were measured according to an enzymatic spectrophotometric method.
RESULTS: Serum MDA level was higher (P = 0.001) whereas paraoxonase 1 activity was lower (P = 0.001) in the patient group than the controls. When active and inactive subgroups were compared with the control group, there was a statistically significant difference between each parameter. Serum MDA levels were significantly higher, while paraoxonase 1 activity was lower in the active and inactive rheumatoid arthritis groups than the control group. But there was not any difference between active and inactive patients with RA. There was a negative correlation between MDA levels and paraoxonase 1 activity.
CONCLUSIONS: Increased reactive oxygen species levels in rheumatoid arthritis may result in a pro-oxidation environment, which in turn could result in decreased antioxidant paraoxonase 1 activity and increased MDA levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055108     DOI: 10.1016/j.clinbiochem.2005.06.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  22 in total

1.  Parameters of oxidative stress status in healthy subjects: their correlations and stability after sample collection.

Authors:  Omidreza Firuzi; Premysl Mladenka; Valeria Riccieri; Antonio Spadaro; Rita Petrucci; Giancarlo Marrosu; Luciano Saso
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Paraoxonase and arylesterase levels in rheumatoid arthritis.

Authors:  A Isik; S S Koca; B Ustundag; H Celik; A Yildirim
Journal:  Clin Rheumatol       Date:  2006-04-27       Impact factor: 2.980

3.  Association between rs662 (A > G) and rs854560 (A > T) polymorphisms in PON1 gene and the susceptibility for psoriasis in mestizo population of Western Mexico.

Authors:  A A Hernández-Collazo; Oscar Pérez-Méndez; Victoria López-Olmos; V Delgado-Rizo; J F Muñoz-Valle; Erika Martínez-López; D G Villanueva-Quintero; Carolina Domínguez-Díaz; Mary Fafutis-Morris; Anabell Alvarado-Navarro
Journal:  Mol Biol Rep       Date:  2020-12-07       Impact factor: 2.316

4.  Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection.

Authors:  Fazilet Duygu; Suda Tekin Koruk; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

5.  Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.

Authors:  Shereem Mohamed Olama; Mohammed Mohamed Elarman
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 2.631

6.  Paraoxonase and arylesterase levels in autoimmune thyroid diseases.

Authors:  Hakan Korkmaz; Suzan Tabur; Mesut Ozkaya; Elif Oguz; Umut Elboga; Nurten Aksoy; Ersin Akarsu
Journal:  Redox Rep       Date:  2016-01-21       Impact factor: 4.412

7.  Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma.

Authors:  Feyza Dursun; Ayse Vural Ozec; Huseyin Aydin; Aysen Topalkara; Ayhan Dursun; Mustafa Ilker Toker; Haydar Erdogan; Mustafa Kemal Arici
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

8.  PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.

Authors:  Oscar Zaragoza-García; Iris Paola Guzmán-Guzmán; Ma Elena Moreno-Godínez; José Eduardo Navarro-Zarza; Verónica Antonio-Vejar; Mónica Ramírez; Isela Parra-Rojas
Journal:  Clin Rheumatol       Date:  2020-06-18       Impact factor: 2.980

9.  A systematic review of preclinical studies on the efficacy of taurine for the treatment of rheumatoid arthritis.

Authors:  Aida Malek Mahdavi; Zeinab Javadivala
Journal:  Amino Acids       Date:  2021-04-30       Impact factor: 3.520

10.  Is 4-Hydroxynonenal a Predictive Parameter for the Development of Joint Erosion in Patients With Rheumatoid Arthritis?

Authors:  Gürkan Akgöl; Hasan Ulusoy; Selda Telo; Arif Gülkesen; Tülay Yildirim; Ahmet Kürşad Poyraz; Arzu Kaya
Journal:  Arch Rheumatol       Date:  2016-03-22       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.